PMVP (STOCKS)
PMV Pharmaceuticals, Inc
$1.350000
+0.030000 (+2.27%)
Prev close: $1.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David H. Mack
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $71.99M
- Employees
- 47
- P/E (TTM)
- -0.91
- P/B (TTM)
- 0.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.34 | $-0.41 | +0.0731 | +17.70% |
|
Sep 2025 (Q3)
|
$-0.40 | $-0.41 | +0.0106 | +2.58% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.39 | -0.0190 | -4.86% |
|
Mar 2025 (Q1)
|
$-0.34 | $-0.38 | +0.0419 | +10.97% |
Financial Statements
| Revenues | $6.34M |
| Benefits Costs and Expenses | $86.25M |
| Costs And Expenses | $86.25M |
| Operating Expenses | $86.21M |
| Research and Development | $69.88M |
| Other Operating Expenses | $16.33M |
| Operating Income/Loss | -$86.21M |
| Income/Loss From Continuing Operations After Tax | -$77.74M |
| Income/Loss From Continuing Operations Before Tax | -$79.91M |
| Income Tax Expense/Benefit | -$2.17M |
| Interest Income/Expense After Provision For Losses | $6.34M |
| Interest Income/Expense Operating, Net | $6.34M |
| Net Income/Loss | -$77.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$77.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$77.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.48 |
| Diluted Earnings Per Share | -$1.48 |
| Basic Average Shares | 52,541,613 |
| Diluted Average Shares | 52,541,613 |
| Assets | $116.56M |
| Current Assets | $115.23M |
| Cash | $112.94M |
| Other Current Assets | $2.28M |
| Noncurrent Assets | $1.34M |
| Fixed Assets | $237.00K |
| Other Non-current Assets | $1.10M |
| Liabilities | $11.85M |
| Current Liabilities | $11.42M |
| Accounts Payable | $3.16M |
| Other Current Liabilities | $8.26M |
| Noncurrent Liabilities | $435.00K |
| Equity | $104.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $104.71M |
| Liabilities And Equity | $116.56M |
| Net Cash Flow From Operating Activities | -$73.58M |
| Net Cash Flow From Operating Activities, Continuing | -$73.58M |
| Net Cash Flow From Investing Activities | $70.17M |
| Net Cash Flow From Investing Activities, Continuing | $70.17M |
| Net Cash Flow From Financing Activities | $505.00K |
| Net Cash Flow From Financing Activities, Continuing | $505.00K |
| Net Cash Flow | -$2.90M |
| Net Cash Flow, Continuing | -$2.90M |
| Comprehensive Income/Loss | -$77.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$77.80M |
| Other Comprehensive Income/Loss | -$55.00K |